Animal Models of Thrombotic Thrombocytopenic Purpura: the Tales from Zebrafish

Overview

Journal Haematologica

Specialty Hematology

Date 2020 Apr 3

PMID 32238467

Citations 3

Authors

Paul Coppo

Bernhard Lammle

Affiliations

Soon will be listed here.

Citing Articles

Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.

Ferraresso F, Strilchuk A, Juang L, Poole L, Luyendyk J, Kastrup C Mol Pharm. 2022; 19(7):2175-2182.

PMID: 35642083 PMC: 9621687. DOI: 10.1021/acs.molpharmaceut.2c00033.

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Koneczny I, Tzartos J, Mane-Damas M, Yilmaz V, Huijbers M, Lazaridis K Front Immunol. 2022; 13:834342.

PMID: 35401530 PMC: 8986991. DOI: 10.3389/fimmu.2022.834342.

Autoimmune-mediated renal disease and hypertension.

Boesen E, Kakalij R Clin Sci (Lond). 2021; 135(17):2165-2196.

PMID: 34533582 PMC: 8477620. DOI: 10.1042/CS20200955.

References

Scully M, Cataland S, Peyvandi F, Coppo P, Knobl P, Kremer Hovinga J . Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2019; 380(4):335-346. DOI: 10.1056/NEJMoa1806311. View

Tersteeg C, Roodt J, Van Rensburg W, Dekimpe C, Vandeputte N, Pareyn I . -acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura. Blood. 2016; 129(8):1030-1038. DOI: 10.1182/blood-2016-09-738856. View

Fuchs T, Kremer Hovinga J, Schatzberg D, Wagner D, Lammle B . Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood. 2012; 120(6):1157-64. PMC: 3418712. DOI: 10.1182/blood-2012-02-412197. View

Weyand A, Shavit J . Zebrafish as a model system for the study of hemostasis and thrombosis. Curr Opin Hematol. 2014; 21(5):418-22. PMC: 4170917. DOI: 10.1097/MOH.0000000000000075. View

Alwan F, Vendramin C, Vanhoorelbeke K, Langley K, McDonald V, Austin S . Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura. Blood. 2017; 130(4):466-471. DOI: 10.1182/blood-2016-12-758656. View

Motto D, Chauhan A, Zhu G, Homeister J, Lamb C, Desch K . Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest. 2005; 115(10):2752-61. PMC: 1240119. DOI: 10.1172/JCI26007. View

Levy G, Nichols W, Lian E, Foroud T, McClintick J, McGee B . Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001; 413(6855):488-94. DOI: 10.1038/35097008. View

Rock G, Shumak K, Buskard N, Blanchette V, Kelton J, Nair R . Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med. 1991; 325(6):393-7. DOI: 10.1056/NEJM199108083250604. View

Moake J, Rudy C, Troll J, Weinstein M, Colannino N, Azocar J . Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982; 307(23):1432-5. DOI: 10.1056/NEJM198212023072306. View

10.

Tsai H, Lian E . Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998; 339(22):1585-94. PMC: 3159001. DOI: 10.1056/NEJM199811263392203. View

11.

Kremer Hovinga J, Coppo P, Lammle B, Moake J, Miyata T, Vanhoorelbeke K . Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017; 3:17020. DOI: 10.1038/nrdp.2017.20. View

12.

Peyvandi F, Scully M, Kremer Hovinga J, Cataland S, Knobl P, Wu H . Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. N Engl J Med. 2016; 374(6):511-22. DOI: 10.1056/NEJMoa1505533. View

13.

Coppo P, Cuker A, George J . Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine. Res Pract Thromb Haemost. 2019; 3(1):26-37. PMC: 6332733. DOI: 10.1002/rth2.12160. View

14.

Zheng L, Abdelgawwad M, Zhang D, Xu L, Wei S, Cao W . Histone-induced thrombotic thrombocytopenic purpura in zebrafish depends on von Willebrand factor. Haematologica. 2019; 105(4):1107-1119. PMC: 7109750. DOI: 10.3324/haematol.2019.237396. View

15.

Banno F, Kokame K, Okuda T, Honda S, Miyata S, Kato H . Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood. 2005; 107(8):3161-6. DOI: 10.1182/blood-2005-07-2765. View

16.

Vanhoorelbeke K, De Meyer S . Animal models for thrombotic thrombocytopenic purpura. J Thromb Haemost. 2013; 11 Suppl 1:2-10. DOI: 10.1111/jth.12255. View

17.

van Dorland H, Taleghani M, Sakai K, Friedman K, George J, Hrachovinova I . The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017. Haematologica. 2019; 104(10):2107-2115. PMC: 6886414. DOI: 10.3324/haematol.2019.216796. View

18.

Scully M, Knobl P, Kentouche K, Rice L, Windyga J, Schneppenheim R . Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura. Blood. 2017; 130(19):2055-2063. PMC: 5680611. DOI: 10.1182/blood-2017-06-788026. View

19.

Moake J, Turner N, Stathopoulos N, Nolasco L, Hellums J . Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986; 78(6):1456-61. PMC: 423893. DOI: 10.1172/JCI112736. View

20.

Hie M, Gay J, Galicier L, Provot F, Presne C, Poullin P . Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura. Blood. 2014; 124(2):204-10. DOI: 10.1182/blood-2014-01-550244. View